These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7818248)

  • 1. PMP22 expression in CMT1a neuropathy.
    Hanemann CO; Stoll G; Müller HW
    Ann Neurol; 1995 Jan; 37(1):136. PubMed ID: 7818248
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
    Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
    J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1 neuropathy.
    Roa BB; Greenberg F; Gunaratne P; Sauer CM; Lubinsky MS; Kozma C; Meck JM; Magenis RE; Shaffer LG; Lupski JR
    Hum Genet; 1996 May; 97(5):642-9. PubMed ID: 8655146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New vistas on the pathomechanism of Charcot-Marie-Tooth and related peripheral neuropathies.
    Müller HW
    Ann N Y Acad Sci; 1999 Sep; 883():152-9. PubMed ID: 10586241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
    Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
    Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease.
    Nobbio L; Vigo T; Abbruzzese M; Levi G; Brancolini C; Mantero S; Grandis M; Benedetti L; Mancardi G; Schenone A
    Neurobiol Dis; 2004 Jun; 16(1):263-73. PubMed ID: 15207283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of myelin-specific gene expression. Relevance to CMT1.
    Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
    Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Charcot-Marie-Tooth 1A (CMT1A) neuropathy.
    Hanemann CO; Müller HW
    Trends Neurosci; 1998 Jul; 21(7):282-6. PubMed ID: 9683317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Charcot-Marie-Tooth 1A: heterozygous T118M mutation over a CMT1A duplication has no influence on the phenotype.
    Seeman P; Mazanec R; Marikova T; Rautenstrauss B
    Ann N Y Acad Sci; 1999 Sep; 883():485-9. PubMed ID: 10586280
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemizygous mutation of the peripheral myelin protein 22 gene associated with Charcot-Marie-Tooth disease type 1.
    Numakura C; Lin C; Oka N; Akiguchi I; Hayasaka K
    Ann Neurol; 2000 Jan; 47(1):101-3. PubMed ID: 10632107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Many facets of the peripheral myelin protein PMP22 in myelination and disease.
    Naef R; Suter U
    Microsc Res Tech; 1998 Jun; 41(5):359-71. PubMed ID: 9672419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The "CMT rat": peripheral neuropathy and dysmyelination caused by transgenic overexpression of PMP22.
    Niemann S; Sereda MW; Rossner M; Stewart H; Suter U; Meinck HM; Griffiths IR; Nave KA
    Ann N Y Acad Sci; 1999 Sep; 883():254-61. PubMed ID: 10586250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory demyelination in a patient with CMT1A.
    Vital A; Vital C; Lagueny A; Ferrer X; Ribière-Bachelier C; Latour P; Petry KG
    Muscle Nerve; 2003 Sep; 28(3):373-6. PubMed ID: 12929199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.
    LeGuern E; Gouider R; Mabin D; Tardieu S; Birouk N; Parent P; Bouche P; Brice A
    Ann Neurol; 1997 Jan; 41(1):104-8. PubMed ID: 9005872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duplication analysis in Turkish Charcot-Marie-Tooth type 1A patients using short tandem repeat markers.
    Koç F; Güzel AI; Sarica Y; Kasap H
    Int J Neurosci; 2007 Nov; 117(11):1611-9. PubMed ID: 17917930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trembler as a mouse model of CMT1A?
    Garbay B; Salles J; Knoll A; Boiron-Sargueil F; Heape AM; Bonnet J; Cassagne C
    Ann N Y Acad Sci; 1999 Sep; 883():262-72. PubMed ID: 10586251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation testing in Charcot-Marie-Tooth neuropathy.
    Nicholson GA
    Ann N Y Acad Sci; 1999 Sep; 883():383-8. PubMed ID: 10586262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrastructural PMP22 expression in inherited demyelinating neuropathies.
    Vallat JM; Sindou P; Preux PM; Tabaraud F; Milor AM; Couratier P; LeGuern E; Brice A
    Ann Neurol; 1996 Jun; 39(6):813-7. PubMed ID: 8651657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy-translocation to the X chromosome.
    King PH; Waldrop R; Lupski JR; Shaffer LG
    Clin Genet; 1998 Nov; 54(5):413-6. PubMed ID: 9842994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pathology of Charcot-Marie-Tooth disease type 1A: abnormal expression of PMP-22].
    Yoshikawa H; Nishimura T; Yanagihara T
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1441-3. PubMed ID: 8752424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.